4//SEC Filing
VERNON W ANTHONY 4
Accession 0001562180-25-004429
CIK 0001645113other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:14 PM ET
Size
5.7 KB
Accession
0001562180-25-004429
Insider Transaction Report
Form 4
NovoCure LtdNVCR
VERNON W ANTHONY
Director
Transactions
- Sale
Ordinary Shares
2025-06-03$17.35/sh−999$17,329→ 167,887 total
Footnotes (3)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $17.1025 USD to $17.50 USD; the price reported above reflects the weighted average sale price.
- [F3]Amended total to correct prior mathematical error.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001369091
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:14 PM ET
- Size
- 5.7 KB